Immunovant (IMVT) Current Assets (2018 - 2026)
Immunovant's Current Assets came in at $851.18 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 30.6% from $651.76 million a year earlier but down 10.3% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Current Assets was $948.82 million, up 23.6% from FY2025.
- Current Assets has increased in each of the last three fiscal years, with a five-year compound annual growth rate of 18.3% (FY2021 to FY2026).
- Going back by fiscal year, Current Assets was $767.66 million in FY2025 (+15.3%), $665.77 million in FY2024 (+64.7%), $404.33 million in FY2023 (-21.2%) and $512.93 million in FY2022 (+25.4%).
- The five-year range for quarterly Current Assets is $291.18 million (fiscal Q2 2024) to $1.04 billion (fiscal Q3 2026).
- Year-over-year, Current Assets has increased for six consecutive quarters, with growth averaging 34.8% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in fiscal Q3 2026 (growth of 152.8%), and the weakest in fiscal Q3 2025 (a decline of 42.0%).
- Business Quant data shows IMVT's Current Assets at $948.82 million (Q4 2026), $1.04 billion (Q3 2026) and $573.55 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 851.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 851.18 Mn |
| Mar 31, 2026 | 948.82 Mn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 573.55 Mn |
| Jun 30, 2025 | 651.76 Mn |
| Mar 31, 2025 | 767.66 Mn |
| Dec 31, 2024 | 412.54 Mn |
| Sep 30, 2024 | 507.37 Mn |
| Jun 30, 2024 | 589.05 Mn |
| Mar 31, 2024 | 665.77 Mn |
| Dec 31, 2023 | 710.78 Mn |
| Sep 30, 2023 | 291.18 Mn |
| Jun 30, 2023 | 350.02 Mn |
| Mar 31, 2023 | 404.33 Mn |
| Dec 31, 2022 | 454.42 Mn |
| Sep 30, 2022 | 426.09 Mn |
| Jun 30, 2022 | 456.30 Mn |
| Mar 31, 2022 | 512.93 Mn |
| Dec 31, 2021 | 540.48 Mn |
| Sep 30, 2021 | 563.79 Mn |
API Access
Immunovant Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();